Vaxart appoints Board member Mark Watson as Lead Independent Director

– USA, CA –  Vaxart, Inc. (OTC: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, announced the appointment of Mark Watson as Lead Independent Director.…